Email updates

Keep up to date with the latest news and content from Filaria Journal and BioMed Central.

Open Access Research

Homologs of the Brugia malayi diagnostic antigen BmR1 are present in other filarial parasites but induce different humoral immune responses

Rahmah Noordin1*, Ros Azeana Abdul Aziz1 and Balachandran Ravindran2

Author Affiliations

1 Institute for Research in Molecular Medicine and School of Medical Sciences, Universiti Sains Malaysia, Malaysia

2 Division of Immunology, Regional Medical Research Centre, Indian Council of Medical Research, Bhubaneswar, India

For all author emails, please log on.

Filaria Journal 2004, 3:10  doi:10.1186/1475-2883-3-10

The electronic version of this article is the complete one and can be found online at: http://www.filariajournal.com/content/3/1/10


Received:27 March 2004
Accepted:31 December 2004
Published:31 December 2004

© 2004 Noordin et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

The recombinant antigen BmR1 has been extensively employed in both ELISA and immunochromatographic rapid dipstick (Brugia Rapid) formats for the specific and sensitive detection of IgG4 antibodies against the lymphatic filarial parasites Brugia malayi and Brugia timori. In sera of individuals infected with Wuchereria bancrofti the IgG4 reactivity to BmR1 is variable, and cross-reactivity of sera from individuals infected with Onchocerca volvulus or Loa loa was observed only in single cases. In order to characterize the homologs of the BmR1 antigen in W. bancrofti (Wb-BmR1), O. volvulus (Ov-BmR1) and L. loa (Ll-BmR1) the cDNA sequences were identified, the protein expressed and the antibody reactivity of patients' sera was studied.

Methods

PCR methodology was used to identify the cDNA sequences from cDNA libraries and/or genomic DNA of W. bancrofti, O. volvulus and L. loa. The clones obtained were sequenced and compared to the cDNA sequence of BmR1. Ov-BmR1 and Ll-BmR1 were expressed in E. coli and tested using an IgG4-ELISA with 262 serum samples from individuals with or without B. malayi, W. bancrofti, O. volvulus and L. loa infections or various other parasitic infections. BmR1, Ov-BmR1 and Ll-BmR1 were also tested for reactivity with the other three IgG subclasses in patients' sera.

Results

Wb-BmR1 was found to be identical to BmR1. Ov-BmR1 and Ll-BmR1 were found to be identical to each other and share 99.7% homology with BmR1. The pattern of IgG4 recognition of all serum samples to BmR1, Ov-BmR1 and Ll-BmR1 were identical. This included weak IgG4 reactivities demonstrated by L. loa- and O. volvulus-infected patients tested with Ov-BmR1 and Ll-BmR1 (or BmR1). With respect to reactivity to other IgG subclasses, sera from O. volvulus- and L. loa-infected patients showed positive reactions (when tested with BmR1, Ov-BmR1 or Ll-BmR1 antigens) only with IgG1. No reactivity was observed with IgG2 or with IgG3. Similarly, ELISAs to detect reactivity to other anti-filarial IgG subclasses antibodies showed that sera from individuals infected with B. malayi or W. bancrofti (active infections as well as patients with chronic disease) were positive with BmR1 only for IgG1 and were negative when tested with IgG2 and with IgG3 subclasses.

Conclusions

This study demonstrates that homologs of the BmR1 antigen are present in W. bancrofti, O. volvulus and L. loa and that these antigens are highly conserved. Recognition of this antigen by patients' sera is similar with regard to IgG1, IgG2 and IgG3, but different for IgG4 antibodies. We conclude that the BmR1 antigen is suitable for detection of IgG4 antibodies in brugian filariasis. However, its homologs are not suitable for IgG4-based diagnosis of other filarial infections.

Background

Lymphatic filariasis (LF) caused by Brugia malayi and Brugia timori is endemic in several Asian countries and infects approximately 13 million people. In May 2000, The Global Program for Elimination of Lymphatic Filariasis (GPELF http://www.filariasis.org/ webcite) was officially formed with the goal of eliminating the disease as a public health problem by the year 2020. To this end, sensitive and specific field-applicable diagnostic tools are required for mapping the distribution of the disease and monitoring the various phases of the program. Many areas endemic for LF are remote and have poor access to well-equipped laboratories, thus a rapid and field-applicable diagnostic test is important to ensure that it can be easily be performed by field workers and reliable, reproducible, results can be obtained. For bancroftian filariasis caused by Wuchereria bancrofti, the ICT antigen card test (Binax Inc., USA http://www.binax.com/ webcite) is widely used for this purpose. This test is based on the detection of a circulating adult worm antigen of W. bancrofti. Although this antigen is also present in Brugia [1], a reliable antigen detection test for human B. malayi infection is not available. Therefore, despite its inconvenience and insensitivity, routine diagnosis of brugian filariasis is made by light microscopy of night blood.

Although PCR assays are highly sensitive, these mainly detect individuals with circulating microfilariae (mf); and they are both time consuming and labour-intensive requiring well-equipped laboratory facilities.

Detection of anti-filarial IgG4 antibody provides a good alternative diagnostic tool for brugian filariasis, as this antibody subclass has been shown to be elevated in active infection and decline post-treatment [2-9]. Recombinant antigen-based antibody assays would be preferable over assays based on parasite extracts since the former allow for unlimited supply of well-defined antigens.

The BmR1 recombinant antigen, expressed by gene pPROEXHT/Bm17DIII (GenBank accession no. AF225296), has been shown by us to be a highly specific and sensitive antigen for IgG4 assays to detect exposure to both B. malayi and B. timori infections. The antigen has been used in both ELISA and immunochromatographic rapid dipstick (Brugia Rapid) formats, and evaluation in various laboratories and field trials has revealed a sensitivity of 93%–100% in detecting microfilariaemic individuals [9-13]. Furthermore, in some endemic areas antibodies were also detected in amicrofilaraemic individuals, indicating the sensitivity of the assay in detecting sub-patent infections in brugian filariasis [10,13-15]. The BmR1 antigen is highly specific (99%–100%) with respect to reactivity with sera from non-filarial infections [11,12]. The highest prevalence of cross-reacting antibodies in other filarial infections was found in W. bancrofti, followed by Loa loa, while only one sample of nine patients with Dirofilaria infection was found to be reactive. No cross-reactivity was exhibited in patients infected with O. volvulus or Mansonella [11,16].

Due to its diagnostic significance, it is therefore important to characterize the BmR1 antigen more closely. The varying degree of BmR1 recognition in other filarial infection raises the question of whether the homologous antigen is also present in W. bancrofti, L. loa and O. volvulus. In the present study we have shown that BmR1 antigen is highly conserved (99–100% amino acid identity), and that almost identical antigens are present in the other human filarial parasites of public health importance. Interestingly, however, the ability of the hosts to mount IgG4 response to BmR1 homologs was found to be highly variable in some infections. In addition, the antibody responses of other IgG subclasses to BmR1 and its homolog were also investigated.

Materials & methods

cDNA and genomic DNA

W. bancrofti microfilaria (mf), adult male and adult female cDNA libraries were obtained from the Filarial Genome Project Resource Centre (Smith College, Northampton, Massachusetts, USA genome@smith.edu). Genomic DNA of W. bancrofti mf were prepared from samples provided by Dr. B Ravindran, Division of Immunology, Regional Medical Research Centre, Indian Council of Medical Research, Bhubaneswar, India http://icmr.nic.in/ webcite. The samples were comprised of two from individuals whose serum/blood samples were negative by the Brugia Rapid test and two from individuals who were positive by the Brugia Rapid test. L. loa L3 and O. volvulus mf cDNA libraries were kindly provided by Dr. P Fischer, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany http://www.bni.uni-hamburg.de/ webcite.

PCR

To amplify the entire Bm17DIII gene sequence the following PCR primers were used: RNF (24 mer) 5' ATT ACT GAT TAG TAT TTT ATC GTT 3' and RNR (24 mer) 5'ATG ATA AAA ATG AAT GAG AAA TAT 3'. λ phage plaques were amplified and the DNA was extracted using a λ DNA extraction kit (Qiagen, Germany http://www.qiagen.com/ webcite). PCR was then performed in a thermocycler (Perkin Elmer, USA http://www.perkinelmer.com/ webcite) at the following conditions: 94°C, 5 mins.; 55°C, 5 mins.; 35 cycles for 94°C, 45 sec; 55°C, 45 sec & 72°C, 90 sec; 72°C, 10 mins.

Genomic DNA from W. bancrofti mf was prepared using Genispin Tissue DNA Kit (BioSynTech, Malaysia http://www.biosyntech.com/ webcite). PCR amplifications using the above primers were then performed using the following thermocycler conditions: 94°C, 5 mins; 35 cycles for 94°C, 1 min; 55°C, 1 min & 72°C, 1 min; 72°C, 10 mins.

TOPO cloning and DNA sequence analysis

For sequence analysis of the gene homologs in W. bancrofti, O. volvulus and L. loa, the PCR products were cloned into TOPO-TA vector (Invitrogen, USA http://www.invitrogen.com/ webcite), then transformed into E. coli TOP10 host (Invitrogen, USA http://www.invitrogen.com/ webcite). The recombinant plasmids were then amplified, purified using QIAprep® Spin Miniprep Kit (Qiagen, Germany http://www.qiagen.com/ webcite), and subsequently sent for sequencing (ACGT Inc, USA http://www.acgtinc.com/ webcite). The results of the DNA sequences were analyzed using vector NTI software (Invitrogen, USA http://www.invitrogen.com/ webcite).

Subcloning, expression and purification of Ov17DIII/Ll17DIII

The Bm17DIII gene homologs in O. volvulus and L. loa were subcloned into a bacterial expression vector, pPROEX-HT which contain 6-His tag (Life Technologies, USA http://www.invitrogen.com/ webcite), then transformed into E. coli TOP 10 host cells.

The recombinant bacteria were cultured in Terrific broth and placed in a shaker incubator at 37°C until the optical density reached 0.5. The culture was then induced with 1 mM IPTG (isopropyl β-D-thiogalactopyranoside) for 3 hrs at 30°C. The bacterial pellet was reconstituted with lysis buffer containing 50 mM Tris HCl (pH 8.5), 5 mM 2-mercaptoethanol and a cocktail of protease inhibitors (Roche Diagnostics, Germany http://www.roche-diagnostics.com/ webcite). The suspension was sonicated at 200 W for 10 minutes, followed by centrifugation at 12 000 g for 30 minutes. The resulting supernatant was purified using Ni-NTA resin (Qiagen, Germany http://www.qiagen.com/ webcite) and buffers containing imidazole. The protein-containing fractions were then pooled.

ELISA

The methodology employed was as previously reported [9]. Briefly, microtiter wells (Nunc, USA http://www.nalgenunc.com/ webcite) were coated with 100 μl of either BmR1 (20 μg/ml) or the homologous recombinant antigens (5, 10 or 20 μg/ml) in NaHCO3 buffer (pH 9.6). After a blocking step, serum samples (1:20 or 1:50 or 1:100) were incubated for 2 h, followed by 0.5 h incubation with the secondary antibody HRP conjugated to monoclonal anti-human IgG1 (1:6000), IgG2 (1:1000, 1:2000), IgG3 (1:1000, 1:2000) or IgG4 (1:4500) (CLB Sanquin Blood Supply Foundation, Netherlands http://www.sanquin.nl/ webcite). Subsequently ABTS substrate (Roche Diagnostics, http://www.roche-diagnostics.com/ webcite) was added for 30 minutes before the optical densities (OD) were read at 410 nm with an ELISA spectrophotometer (Dynatech (now DYNEX Technologies), USA http://www.dynextechnologies.com/ webcite).

Serum samples were from existing serum banks, collected according to the ethical requirements of each institution. The samples were as follows: O. volvulus, L. loa, W. bancrofti, B. malayi and other parasitic infections. In addition serum samples from endemic normals (healthy and Brugia Rapid negative individuals from endemic areas in Malaysia) and non-endemic normals (healthy blood donors from Malaysia) were also tested. The O. volvulus sera were from microfilaremic from western Uganda [17]. L. loa sera were from microfilaremic individuals from the clinical department of the Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany. W. bancrofti sera samples were from India; while sera from B. malayi infections, endemic normals, non-endemic normals and other parasitic infections were from Malaysia. Infections with other parasites comprised of patients from Malaysia:

• whose stool specimens were positive for parasite ova/larva (single or mixed infections with Ascaris lumbricoides, Trichuris trichiura, hookworm, Strongyloides stercoralis)

• with clinical presentation and serology consistent with toxocariasis and amoebiasis

• with Gnathostoma spinigerum isolated from the eye (one patient)

Results

Identification of the BmR1 homolog in W. bancrofti, O. volvulus and L. loa

In order to explain the pattern of antigen recognition in patients with other filarial infection we identified the homologs of the BmR1 antigen in W. bancrofti (Wb-BmR1), O. volvulus (Ov-BmR1) and L. loa (LI-BmR1). PCR of W. bancrofti cDNA libraries and W. bancrofti genomic DNA (from all 4 mf samples) produced a single band of 618 bp. PCR products were eluted from band 618 and cloned into TOPO vector. A total of 12 recombinant clones from six TOPO reactions (2 from mf cDNA, 1 from adult female cDNA, 1 from adult male cDNA and 2 from mf genomic DNA) were sequenced. A total of 31 DNA sequencing reactions were analyzed and all obtained sequences were identical. Comparison of the obtained nucleotide sequence showed that it was identical to cDNA sequence of BmR1, irrespective whether the template DNA came from cDNA libraries, or microfilaria originated from individuals positive or negative for Brugia Rapid.

For identification of the cDNA of the Ov-BmR1 and Ll-BmR1, a total of 5 and 3 recombinant clones were sequenced, respectively (comprising a total of 20 reactions). The Ov-BmR1 and Ll-BmR1 were 100% identical to each other, and only two base pairs were different from BmR1 and Wb-BmR1 i.e. at 97 bp and 483 bp. When the amino acid sequences were compared only one amino acid difference was observed: the uncharged polar isoleucine at position 33 was substituted by a neutral threonine (Figure 1).

thumbnailFigure 1. a) Nucleotide sequence of Bm17DIII and its homologs in W. bancrofti, O. volvulus and L. loa. Top sequence data shows DNA sequences of Bm17DIII and its homologs in W. bancrofti, O. volvulus and L. loa. b) Amino acid sequence of BmR1 and its homologs in W. bancrofti, O. volvulus and L. loa. Bottom sequence data shows amino acid sequence of BmR1 and its homologs in W. bancrofti (Wb-BmR1), O. volulus (Ov-BmR1) and L. loa (Ll-BmR1). Comparison between Bm17DIII DNA sequence and its DNA homologs in O. volvulus and L. loa showed only two bases difference at 98 and 483. BmR1 homologs of the amino acid sequence was identical with W. bancrofti. However, with O. volvulus and L. loa a difference occurred only at one amino acid coded by bases 97–99 i.e. a change from Ile (ATC) to Thr (ACC).

Antibody reactivity to BmR1, Ov-BmR1 and Ll-BmR1 recombinant antigens

For IgG4-ELISA, serum samples that demonstrated average optical density (OD) readings of ≥0.300 were considered to be positive [9]. The comparison of IgG4 reactivites with BmR1 and its homologs (Ov-BmR1 and Ll-BmR1) using a panel of 201 sera samples from individuals with various parasitic infections and 61 healthy controls (29 endemic normals and 32 non-endemic normals) indicated that the exchange of one amino acid had no influence on the reactivity of IgG4 antibodies. The IgG4-ELISA results showed all recombinant antigens were identical in reactivity with the various categories of sera (Table 1).

Table 1. Comparison among IgG4 reactivities of BmR1, Ov-BmR1 and Ll-BmR1 using a panel of serum samples from patients with various parasitic infections and healthy controls (endemic and non-endemic normals). BmR1 is the antigen expressed by Bm17DIII DNA sequence; while Ov-BmR1 and Ll-BmR1 are the antigens expressed by the homologs of Bm17DIII DNA sequence in O. volvulus and L. loa respectively.

Reactivities of BmR1 and its homologs (Ov-BmR1 and Ll-BmR1) with serum antibodies of the other three IgG subclasses (IgG1, IgG2 and IgG3) using samples from O. volvulus and L. loa infected individuals showed positive reactions with only IgG1. Most IgG1 positive samples had an OD >1.000. Similarly, the reactivities of anti-filarial IgG1, IgG2 and IgG3 antibody subclasses with BmR1 on serum samples from active and chronic cases of W. bancrofti and B. malayi showed positive reactions only with IgG1. It is also noted that sera from non-endemic normals and soil-transmitted infections also showed similar reactivities i.e. IgG1 positive and IgG2- & IgG3-negative (Table 2).

Table 2. Results of ELISAs to detect IgG1, IgG2 and IgG3 anti-filarial antibodies in serum samples from patients with various helminthiasis and healthy controls (non-endemic normals) using BmR1, Ov-BmR1 and Ll-BmR1. All antigens (tested separately) demonstrated identical results with all serum samples.

Discussion

BmR1, a recombinant B. malayi antigen of ~30 kDa expressed by Bm17DIII DNA coding sequence (cds), has been consistently shown to be a sensitive and specific antigen for the immunodiagnosis of brugian filariasis in studies employing either ELISA or immunochromatographic rapid test (Brugia Rapid) formats [9,11-13,15]. When compared with the DNA sequences in GenBank, Bm17DIII cds exhibited 94% homology with the reported EST sequence derived from B. malayi microfilaria cDNA (GenBank AW244981). Southern blot hybridization assays performed on cDNA libraries of L3, L4, mf, adult male and adult female B. malayi showed that it is present in all of the above stages (Rahmah et al., unpublished data). Bands of the correct molecular weight were observed in a Western blot of B. malayi mf, adult male and adult female soluble antigens probed with monopurified antibody to BmR1 (Rahmah et al., unpublished data).

Multicenter evaluations performed with Brugia Rapid showed variable reactivity of BmR1 to sera of W. bancrofti-infected patients. Reactivity to sera from Chennai, India was 54.5% (12/22); from Indonesia was 70% (14/20) and from the Cook Islands was 90% (9/10) [12,15]. The wide variation in the reactivity of the assay in Bancroftian filariasis in the above three geographical areas prompted us to undertake the current investigation. The present study has shown that the homolog in W. bancrofti is identical to the cDNA of BmR1 – irrespective of the source of the parasites – whether the mf were isolated from the individuals whose sera showed positive or negative reactivity with the Brugia Rapid test. Thus the observed differences in the reactivity of BmR1 antigen with W. bancrofti sera collected from different geographical regions does not appear to be due to genotypic variability between different isolates of mf. Further studies are currently underway to determine if the variability in the expression of the gene could account for the variability in the Brugia Rapid results with serum samples collected from W. bancrofti infected individuals.

PCR experiments were performed on the W. bancrofti genomic DNA samples to obtain an amplicon with a size greater than 618 bp (since an intron is expected to be present in genomic material). However, only one prominent band of 618 bp was obtained (very occasionally a faint band of >1 kb was observed which was shown later to be due to unspecific amplification). PCR on W. bancrofti genomic DNA to amplify the intron sequence (using primers based on the Bm17DIII intron) produced a sequence that shared ~75% homology to the intron of Bm17DIII. This is believed to be an amplification on another part of W. bancrofti genome, since PCR using a pair of internal primers that flank the possible intron site produced a PCR product of ~300 bp (a size that is expected if there was no intron). Conversely, amplification of B. malayi genomic material produced two kinds of amplicons: 618 bp and 1010 bp. The latter was comprised of an intron (393 bp) and two flanking exons (237 bp and 381 bp), the sequences of which were consistent with B. malayi data at TIGR website http://www.tigr.org/ webcite. Thus at Universiti Sains Malaysia, genomic DNA of Wb17DIII was found to be intronless, whereas genomic DNA of Bm17DIII was shown to have two variants (i.e one with and one without an intron). These results, though seemingly controversial, were a result of exhaustive efforts with appropriate PCR controls. Data from other laboratories will hopefully confirm these results.

Anti-BmR1 IgG4 was detected in 84.6% (44/52) of L. loa sera but generally not detected in O. volvulus serum samples [11,16]. Ov-BmR1 and Ll-BmR1 were identical to each other and 99.7% similar to BmR1 (and to Wb-BmR1) on the nucleotide level (Figure 1). Ov-BmR1 and Ll-BmR1 were found to display identical reactivity compared to BmR1 when tested with IgG4-ELISA on a panel of serum samples (Tables 1 &2). Therefore, the difference of one amino acid between BmR1 and its homologs (Ov-BmR1 and Ll-BmR1) did not alter their antigenicity. It is interesting to note that although IgG4 has been shown to be elevated in onchocerciasis with assays using other recombinant antigens [18,19], the IgG4 reactivity to BmR1 or Ov-BmR1 in O. volvulus was generally negative. One possible explanation for this is that adult worms mostly express Ov-BmR1 and the immune response to O. volvulus is predominantly due to mf [20]. This may explain the very poor IgG4 response to BmR1 and Ov-BmR1. It is possible that the uptake of antigen from lymphatic filariae by antigen presenting cells is significantly different compared to O. volvulus (where adult worms and mf reside either in sub-dermal nodules or in the skin).

The BmR1, Ov-BmR1 and Ll-BmR1 recombinant antigens were also used to determine if IgG1, IgG2 or IgG3 antibodies in O. volvulus and L. loa serum samples were reactive with the recombinant proteins. In addition, the three IgG subclasses were also tested with BmR1 on assays using sera collected from patients with B. malayi and W. bancrofti infections. In all cases only anti-filarial IgG1 was reactive, while anti-filarial IgG2 and IgG3 assays were consistently negative. It is important to note that IgG1 antibodies to BmR1 and its homologs are unspecific and without any diagnostic value. The BmR1 antigen obviously contains widespread epitopes that are recognized by IgG1 antibodies.

Thus based on the current study, BmR1 and its homologs in W. bancrofti, O. volvulus and L. loa induce IgG antibody responses restricted to IgG1 and IgG 4 subclasses only. Unlike the anti-filarial IgG4 response in B. malayi infection, the IgG4 response to BmR1 in W. bancrofti and L. loa was not consistently detected in all infected individuals, indicating that this recombinant antigen will not be of much use in the diagnosis of these two filarial infections. Although IgG1 response to BmR1 was observed in all the filarial infections tested, it lacks specificity since it was also positive when tested with serum samples from normal individuals and with those infected with other parasites.

Conclusions

The study demonstrates the presence of identical and almost identical homologs of the diagnostic BmR1 antigen in other filarial parasites. However, they do not seem to induce consistent antibody responses in all infected subjects. Thus the immunogenicity of BmR1 in brugian filariasis appears to be clearly different from that of bancroftian filariasis, onchocerciasis and loiasis.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

RN – was the principle researcher, designed the study, supervised the experiments and result analysis, wrote the first draft of the manuscript.

RAAA – performed the experiments and participated in the analysis of the data.

BR – provided parasite materials, collected patients' sera, edited the paper.

Acknowledgements

These studies received financial support from Malaysian Government IRPA grant no 06-02-05-1007PR0016/06-05 and European Commission (EC) grant, No. ICA4-CT-2001-10081. We would also like to thank Dr. Peter Fischer from Bernhard Notch Institute for Tropical Medicine, Hamburg, Germany for providing the parasite material, sera samples and helpful comments.

References

  1. Chandrashekar R, Yates JA, Weil GJ: Use of parasite antigen detection to monitor macrofilaricidal therapy in Brugia malayi-infected jirds.

    J Parasitol 1990, 76:122-124. PubMed Abstract OpenURL

  2. Ottesen EA, Skvaril LF, Tripathy S, Poindexter RW, Hussain R: Prominence of IgG4 in the IgG response to human filariasis.

    J Immunol 1985, 134:2707-2712. PubMed Abstract | Publisher Full Text OpenURL

  3. Kwan-Lim GE, Forsyth KP, Maizels RM: Filarial-specific IgG4 responses correlates with active Wuchereria infection.

    J Immunol 1990, 145:4298-4305. PubMed Abstract | Publisher Full Text OpenURL

  4. Kurniawan A, Yazdanbakhsh M, van Ree R, Aaberse R, Selkirk ME, Partono F, Maizels RM: Differential expression of IgE and IgG4-specific antibody responses in asymptomatic and chronic human filariasis.

    J Immunol 1993, 150:3941-3950. PubMed Abstract | Publisher Full Text OpenURL

  5. Haarbrink M, Terhell A, Abadi K, van Beers S, Asri M, de Medeiros F, Yazdanbakhsh M: Anti-filarial IgG4 in men and women living in Brugia malayi endemic areas.

    Trop Med Int Health 1999, 4(2):93-97. PubMed Abstract | Publisher Full Text OpenURL

  6. Wamae CN, Roberts JM, Eberhard ML, Lammie PJ: Kinetics of circulating IgG4 after diethylcarbamazine and ivermectin treatment of bancrotian filariasis.

    J Infect Dis 1992, 165:1158-1160. PubMed Abstract OpenURL

  7. Kurniawan A, Atkinson R, Sartono E, Partono F, Yazdanbakhsh M, Maizels RM: Differential decline in filarial specific IgG1, IgG4 and IgE antibodies in Brugia malayi infected patients after diethylcarbamazine therapy.

    J Infect Dis 1995, 172:1567-1572. PubMed Abstract OpenURL

  8. McCarthy JS, Guinea A, Weil GJ, Ottesen EA: Clearance of circulating filarial antigen as a measure of the macrofilaricidal activity of diethylcarbamazine in Wuchereria bancrofti infection.

    J Infect Dis 1995, 172:521-526. PubMed Abstract OpenURL

  9. Rahmah N, Lim BH, Khairul Anuar A, Shenoy RK, Kumaraswami V, Lokman Hakim S, Chotechuang P, Kanjanopas K, Ramachandran CP: A recombinant antigen-based IgG4 ELISA for the specific and sensitive detection of Brugia malayi detection.

    Trans R Soc Trop Med Hyg 2001, 95(3):280-284. PubMed Abstract | Publisher Full Text OpenURL

  10. Supali T, Rahmah N, Djuardi T, Sartono E, Ruckert P, Fischer P: Detection of IgG4 antibodies using Brugia Rapid test in individuals from an area highly endemic for Brugia timori.

    Acta Tropica 2004, 90(3):255-261. PubMed Abstract | Publisher Full Text OpenURL

  11. Rahmah N, Shenoy RK, Nutman TB, Weiss N, Gilmour K, Maizels RM, Yazdanbakhsh M, Sartono E: Multicenter laboratory evaluation of Brugia Rapid dipstick test for detection of brugian filariasis.

    Trop Med Int Health 2003, 8(10):895-900. PubMed Abstract | Publisher Full Text OpenURL

  12. Rahmah N, Supali T, Shenoy RK, Lim BH, Kumaraswami V, Khairul Anuar A, Lokman Hakim S, Noor Hayati MI, Chan BT, Suharni M, Ramachandran CP: Specificity and sensitivity of a rapid dipstick test (Brugia Rapid) in the detection of Brugia malayi infection.

    Trans R Soc Trop Med Hyg 2001, 95:601-604. PubMed Abstract | Publisher Full Text OpenURL

  13. Lim BH, Rahmah N, Afifi SAB, Ramli A, Mehdi R: Comparison of Brugia-ELISA and thick blood smear examination in a prevalence study of brugian filariasis in Setiu, Terengganu, Malaysia.

    Med J Malaysia 2001, 56:491-496. PubMed Abstract OpenURL

  14. Jamail M, Andrew K, Junaidi D, Krishnan AK, Faizal M, Rahmah N: Field validation of sensitivity and specificity of a rapid test for detection of Brugia malayi infection.

    , in press.

  15. Rahmah N, Lim BH, Azian H, Tengku Ramelah TS, Rohana AR: Short communication: Use of a recombinant antigen-based ELISA to determine prevalence of brugian filariasis among Malaysian School children near Pasir Mas, Kelantan – Thailand border.

    Trop Med Int Health 2003, 8:158-163. PubMed Abstract | Publisher Full Text OpenURL

  16. Fischer P, Bonow I, Supali T, Ruckert P, Rahmah N: Combination of serological and PCR-based assays for screening of blood spots to detect Brugia timori infections.

    , in press.

  17. Fischer P, Kipp W, Bamuhiga J, Binta-Kahwa J, Kiefer A, Buttner DW: Parasitological and clinical characterization of Simulium neavei-transmitted onchocerciasis in western Uganda.

    Trop Med Parasitol 1993, 44:311-321. PubMed Abstract OpenURL

  18. Lucius R, Kern A, Seeber F, Pogonka T, Willenbucher J, Taylor HR, Pinder M, Ghalib HW, Schulz-Key H, Soboslay P: Specific and sensitive IgG4 immunodiagnosis of onchocerciasis with recombinant 33 kD Onchocerca volvulus protein (Ov33).

    Trop Med Parasitol 1992, 43:139-143. PubMed Abstract OpenURL

  19. Chandrashekar R, Ogunrinad AF, Weil GJ: Use of a recombinant Onchocerca volvulus antigens for diagnosis and surveillance of human onchocerciasis.

    Trop Med Int Health 1996, 1:575-580. PubMed Abstract OpenURL

  20. Kazura JW, Nutman TB, Greene BM: Filariasis. In In Immunology and molecular biology of parasitic infections. 3rd edition. Edited by Warren KS. Blackwell Scientific Publications, Oxford; 1993:473-495. OpenURL